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Background: In vitro fertilisation (IVF) treatment provides an opportunity to study early developmental responses
to periconceptional dietary interventions. Retrospective studies have suggested links between preconception diet
and fertility, and more recently, a “Mediterranean” diet has been reported to increase pregnancy rates by up to
40%. In addition, a prospective study examining increased intake of omega-3 polyunsaturated fats demonstrated a
quickened rate of embryo development after IVF. However, up to now, few prospective randomised controlled trials
have investigated the impact of periconceptional dietary interventions on fertility outcomes.
Methods and design: The study is a randomised controlled trial of a dietary intervention consisting of olive oil for
cooking, an olive oil based spread, and a daily supplement drink enriched with Vitamin D (10 microgram daily) and
marine omega-3 fatty acids (2 g daily) for 6 weeks preconception versus a control diet of sunflower seed oil for
cooking, a sunflower oil based spread, and a daily supplement drink without added Vitamin D or marine omega-3
fatty acids. Couples undergoing IVF will be randomised to either the intervention or control group (55 in each arm).
The primary endpoint is embryo developmental competency in vitro, measured by validated morphokinetic
markers. Secondary outcomes will include the effect of the dietary intervention on the nutritional content of the
intrauterine environment.
Discussion: This approach will enable rigorous examination of the impact of the dietary intervention on early
embryo development, together with the influence of the peri-implantation intra-uterine nutritional environment.
Trial registration: ISRCTN50956936Background
Large prospective cohort studies have demonstrated the
impact of female and male preconceptional nutritional
status on fertility, perinatal and long term health of the
offspring [1]. More recently, research has shown that
variations in preconceptional diet may impact IVF out-
comes. A ‘Mediterranean’ diet high in vegetable oils, fish,
vegetables and legumes and low in carbohydrate-rich
snacks was positively associated with red blood cell fol-
ate and vitamin B6 in blood and follicular fluid and with* Correspondence: Alexandra.Kermack@uhs.nhs.uk
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unless otherwise stated.a 40% increase in the probability of pregnancy [2]. The
findings of a subsequent case control study by another
research group also suggested that fertility outcomes
were improved in couples with a Mediterranean diet [3].
In a further prospective study of the association between
dietary intake of polyunsaturated fatty acids, significant
correlations were observed between the reported dietary
intake of the omega-3 fatty acids (FAs) alpha-linolenic acid
and docosahexaenoic acid (DHA) and embryo morph-
ology after IVF [4]. Despite this, no large prospective ran-
domised intervention studies have investigated the impact
of optimising the periconceptional diet on fertility out-
comes, perinatal or child health outcomes [5]. Moreover,
it remains unclear by which mechanisms nutritional modi-
fications act to impact embryo quality, implantation and
subsequent periconceptional and perinatal development.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ies derives from the challenges involved in encouraging
and monitoring compliance to specific dietary regimens,
particularly when the intervention is rigorous and/or of
long duration. However, recent data, primarily from ro-
dent studies demonstrate that dietary manipulations
within a very short window around the time of implant-
ation can have profound effects on early development [6].
Administration of a maternal low protein diet during the
4 days of mouse pre-implantation development, followed
by a control diet thereafter resulted in clear adaptive re-
sponses such as altered blastocyst numbers, upregulation
of endocytosis into the yolksac, and an increase in the rate
of trophoblast invasion. While these adaptive responses
were observed to protect growth, they appeared to
come at the cost of hypertension and abnormal behav-
iour patterns in adulthood [7]. Another group has
shown that administering a high fat diet in this short
period results in altered zygote viability [8], while treating
with an insulin sensitizer during this period normalises
the effects of obesity on oocyte quality and developmental
competence [9].
While extrapolation from rodents to humans brings
uncertainties, this work suggests that a relatively brief
dietary intervention in the 6 weeks prior to conception
could have measureable effects on biomarkers of gamete
and embryo health, the intra-uterine nutritional environ-
ment, and subsequent fetal and placental development,
with implications for the long-term health of the offspring.
Such a short period is likely to increase willingness to take
part in a dietary intervention study and improve compli-
ance during the intervention period. In addition, some
lipid pools will have achieved maximal, or near-maximal,
changes in eicosapentaenoic acid (EPA) and docosahexae-
noic acid (DHA) content within 6 weeks [10].
Studying the impact of short-term interventions in
the general population is complicated by the difficulty
of accessing couples in this preconceptional phase, and
the relatively low probability of subsequent conception
within one or two months of completing the intervention.
These challenges are markedly alleviated in a population
attempting to conceive by means of assisted conception
techniques. Couples reporting for fertility treatment are
readily accessed in the periconceptional phase, and have
on average a 30% chance of conceiving in their first cycle
of treatment. It is therefore feasible to study the impact of
a relatively short dietary intervention, which by virtue of
its limited duration is more likely to be adhered to for the
duration required.
A further advantage of this model is the unique access
IVF treatment gives to human gametes, embryos and the
peri-implantation uterine environment. IVF offers a win-
dow on how the complex biological processes in early
human development are affected by nutritional status.At the time of oocyte retrieval in IVF, follicular fluid and
blood can be sampled and analysed for nutritional bio-
markers. Since the fate of the oocyte can be followed in
terms of morphology, fertilisation and embryo develop-
ment, direct correlations between the nutritional environ-
ment of the developing oocyte and spermatozoa and IVF
outcomes can be ascertained, as our group and others
have shown previously [11]. At the oocyte level, high fat
diets in rodents have been shown to lead to lipid accumu-
lation and endoplasmic reticulum (ER) stress [12], while
follicular fluid folate levels have been shown to correlate
to embryo quality [13].
Embryo quality can be assessed in terms of implant-
ation potential on the basis of morphological and devel-
opmental criteria. The recent availability of incubators
fitted with time lapse video monitoring technologies rep-
resents a step change in the ability to time precisely
when key milestones of development are reached (‘mor-
phokinetics’). This non-invasive means of interrogating
early human development is enhanced by the generation
of a video of each embryo allowing detailed analysis of
development markers at a later date [14]. In addition,
analysis of embryo conditioned medium provides further
non-invasive means of assessing the impact of pericon-
ceptional diet on embryo metabolism [15].
Recent techniques developed by our group also allow
us to analyse the impact of preconceptional diet on the
intra-uterine environment. We have previously demon-
strated the utility and practicality of aspirating endomet-
rial secretions at the time of embryo transfer, which
allows the study of the immediate intrauterine environ-
ment encountered by the embryo [16]. It is now clear
that uterine secretions have a key role in providing nu-
tritional support for the pre-implantation embryo and
recently the role of female reproductive tract fluid com-
position on developmental origins of later health has
been highlighted [17]. Current work is investigating the
amino acid and glucose content of human endometrial
fluid. Moreover, we have developed in-vitro models of
embryo-endometrial interaction which provide the
means to study the impact of nutritional interventions
on embryo-endometrial signalling using donated cryo-
preserved embryos [18-20].
These approaches will enable rigorous examination of the
impact of the dietary intervention on early embryo develop-
ment, and the peri-implantation intra-uterine nutritional
environment. Should a significant positive impact of a diet-
ary intervention on early development be demonstrated,
this would have major implications for health policy and
strengthen arguments for the provision of preconceptional
nutritional advice to the general population. The data gen-
erated will inform new approaches to improving precon-
ceptional nutrition, and provide the basis for a major
prospective community based intervention study aimed at
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and feasible dietary intervention on pregnancy outcomes
and child health.
This study will be conducted in compliance with the
protocol, GCP and the applicable regulatory requirements.
Methods and design
Study objective
Although retrospective studies have suggested a link be-
tween preconception diet and human fecundity, several
questions still remain for example which nutrients are
beneficial and how long they need to be taken prior to
conception. This prospective, randomised, controlled trial
(the PREPARE trial (PREconception dietary suPplements
in Assisted REproduction)) aims to address the questions
of the effect of a diet rich in marine omega-3 FAs and
Vitamin D on a developing embryo and the intrauterine
environment.
Hypothesis
Our hypothesis is that a diet rich in marine omega-3
FAs and Vitamin D will be beneficial to a developing
embryo and thus improve morphokinetic markers used
to predict embryo viability and implantation. Further to
this, it is thought that this diet will affect the nutritional
content of the intrauterine environment and alter the
endometrial tissue immune cell populations.
Study population and recruitment
Women participating in the PREPARE trial will be be-
tween the ages of 18 and 41 years, with a body mass index
(BMI) between 20 and 32 kg/m2, and undergoing their first
or second cycle of IVF or in vitro fertilisation – intracyto-
plasmic sperm injection (IVF-ICSI). Their partners must be
using their own sperm and be prepared to provide a fresh
sample prior to the dietary intervention and on the day of
oocyte retrieval (they should not be using frozen sperm or
sperm obtained by surgical retrieval). Additional inclusion
criteria include an anti-műllerian hormone (AMH) of
greater than 7 pmol/l or an antral follicle count (AFC) of
more than 10. Participants must be willing to provide writ-
ten informed consent to participate in the study.
Exclusion criteria are: any medical contraindication to
IVF or IVF-ICSI treatment or to a specific dietary inter-
vention, previously diagnosed diabetes, taking prescribed
medication or herbal remedies apart from simple pain-
killers, and eating oily fish (as defined by the UK Food
Standards Agency) more than once a week.
Eligible patients will be informed about the PREPARE
study during information evenings or their initial con-
sultation with the medical team. A minimum reflection
period of 3 days will be offered. Eligible patients who
wish to participate will be randomised after providing writ-
ten consent. If an eligible patient declines participation,basic characteristics will be obtained to identify any selec-
tion bias (Figure 1).
Study design
The PREPARE trial is a single centre, randomised con-
trolled trial, powered to demonstrate a difference in mean
duration of the second cell cycle (CC2) of embryos gener-
ated by IVF after exposure of the couple to the interven-
tion versus control. Both the male and female in the
intervention group will receive a six week diet of olive oil
for cooking, an olive oil based spread, and a daily supple-
ment drink enriched with Vitamin D (10 micrograms) and
the marine omega-3 FAs EPA (1 g) and DHA (1 g daily)
versus the control diet of sunflower seed oil for cooking, a
sunflower oil based spread, and a daily supplement drink
without vitamin D, EPA or DHA.
Following inclusion into the study but prior to ran-
domisation, consenting participants will be invited to
complete a preconception questionnaire and the short
Southampton Food Frequency Questionnaire (FFQ) in
order to characterise their lifestyle and diet prior to
entry into the study [21]. At this time, samples of blood,
uterine fluid and endometrium will be obtained from the
women in order to provide baseline data of the nutri-
tional and immune cell content prior to the intervention.
The male participants will be asked to provide a semen
sample which will be analysed for concentration, motility
and morphology according to the WHO criteria [22].
The women embarking on the study will undergo ovar-
ian stimulation according to our standard protocol, pro-
vided no abnormality is seen on their baseline scan on day
2 of their cycle. Oocyte retrieval will be performed 36 hours
following the single dose of human chorionic gonado-
trophin (hCG), which promotes oocyte maturation. At the
point of oocyte retrieval, further blood will be taken from
the female participants and the follicular fluid and cumulus
cells that are routinely removed, during IVF-ICSI, from the
oocyte prior to insemination will be snap frozen. A further
semen sample from the males will be analysed according
to the WHO criteria prior to insemination.
The embryos will be cultured in Vitrolife IVF media in a
validated time lapse incubator (Embryoscope, Unisense,
FertiliTech, Denmark) in 5% CO2, 5%O2 and at 37°C.
During the incubation, twenty one plane focal images will
be generated every hour and analysed according to mor-
phological and morphokinetic markers [23]. For women
in whom embryo transfer is possible, uterine fluid aspir-
ation will be carried out prior to the procedure. In those
not undergoing embryo transfers, an endometrial biopsy
will also be performed.
Compliance with the diet will be monitored by a daily
diary completed at home by the couple and by counting
the empty cartons when they are returned to the Fertility
Unit (Figure 2).
Figure 1 Flowchart of eligible patients.
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trial registers identified no other randomised controlled
trials (RCTs) addressing this subject.
Primary and secondary endpoints
The primary endpoint is the mean period in hours for
the cleaved embryos from participants in each arm of
the study to develop from the 2 cell to the 3 cell stage
(CC2). Secondary endpoints include using the Embryo-
scope to examine embryo quality, including S2 (syn-
chrony during second set of cleavage divisions), T5 (time
between fertilisation and the five cell embryo formation)
[14,24], CC3 (duration of the third cell cycle) [24], andFigure 2 Flow chart of study design.the appearance and disappearance of the pronuclei [25].
Nutritional markers, including the concentration of fatty
acids, Vitamins D, B12, and B6, folate, prostaglandin E2
(PGE2) and prostaglandin F2α (PGF2α) will be measured
in blood, endometrial fluid and follicular fluid pre and
post intervention. Changes in endometrial tissue im-
mune cell populations will also be examined. In male
participants, changes in semen quality pre and post diet-
ary intervention will be recorded according to standard
parameters.
Implantation rates and pregnancy outcomes will be re-
corded and analysed. These include antenatal ultrasound
markers; such as crown-rump length at 7 weeks and
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femur length and cross sectional metaphyseal area and pla-
cental volume at 20 weeks gestation. Perinatal measure-
ments including birthweight and length and placenta
dimensions and weight will also be recorded. Participants
will be invited to bring their neonate to undergo a Dual en-
ergy X-ray Absorptiometry (DXA) to measure bone min-
eral content and density soon after birth.
Participating hospitals
This is a single centre study that will be conducted at the
Complete Fertility Centre, a tertiary unit within the Uni-
versity Hospital Southampton NHS Foundation Trust.
Randomisation
After collection of baseline data in the cycle prior to the
intervention commencing, participating couples will be
randomised to one or other of the study arms. The re-
search team will be blinded to the randomisation. Strati-
fication will be performed at randomisation for planned
mode of fertilisation: in vitro fertilisation or intra-
cytoplasmic sperm injection.
Data collection
Data collection will be performed using a case report
form (CRF). Data relating to clinical treatment out-
comes, including embryo quality measurements will be
acquired from the Fertility Unit’s electronic data collec-
tion system. Questionnaire responses will be inputted
electronically into the CRF. Additional data relating to
laboratory assays will be obtained directly from the
laboratory’s database or the respective external labora-
tories and entered into the CRF. This minimises the risk
of transcription errors; however, all data will be verified
and cleansed prior to analysis.
Statistical analysis
Sample size and power considerations
In a previous retrospective study from our group, a diet
rich in the omega-3 FAs was shown to be associated
with improved embryo morphology when assessed on
day 3 post fertilisation. Using a published scoring system
between 1 (highest quality) and 5 (lowest quality), em-
bryos generated in women with a daily mean total intake
of omega-3 FAs in the 4 weeks prior to IVF greater than
1.7 g scored a mean of 0.6 (SE 0.26) points higher than
those embryos derived from a woman reporting an in-
take of <1 g per day. Recently, morphokinetic analysis of
human embryos has shown the duration of key develop-
ment phases to be correlated to standard conventional
morphological criteria, but more highly predictive of im-
plantation potential [14,26]. One of the most sensitive
predictors of implantation has been shown to be CC2.
Embryos with a CC2 shorter than 11.9 hours (pooled SD2.25 hours, but not normally distributed) have been re-
ported to have an implantation rate of 35% compared to
28% when this key developmental step took longer than
11.9 hours. Moreover, in a study correlating morphoki-
netic parameters with static morphology scoring, a CC2
less than 11.9 hours was shown to correlate with an over-
all increase in embryo score of 0.5 points on a 5 point
scale [14]. This is similar in magnitude to the impact on
embryo morphology reported to be achieved by exposure
to a high omega 3 FA diet as described above [4].
The primary end point of this study is therefore the
difference in mean CC2 score of embryos generated by
IVF after exposure of the couple to the intervention ver-
sus control diet. In order to detect a minimum absolute
difference of 12% (1.4 hours) in mean CC2, or effect size
of 0.670, with power ≥80% at p <0.05 a non-parametric
comparison (Wilcoxon test) indicates a requirement of
46 couples per group in the analysis.
To allow for drop outs and failure to produce suffi-
cient viable embryos, a further 20% will be recruited.
This requires the randomisation of a minimum of 55
couples per group (110 in total).
Data analysis
In order to adjust for pre-defined confounders such as
age, AMH level, ovarian stimulation method, fertilisation
method and the number of oocytes obtained, univariate
and multivariate analyses will be performed. This will en-
able the independent contribution of the dietary factor to
the primary and secondary outcome measures to be
quantified.
Differences in embryo quality parameters will be tested
by Wilcoxon testing, and differences in blood and endo-
metrial fluid levels of the stated secondary outcome pa-
rameters will be tested by the Mann Whitney U test.
Ethics
This study is designed using the guidelines for good clinical
practice (GCP) as well as the Declaration of Helsinki 1964
as revised and recognised by governing laws and EU Direc-
tives. Full ethical approval (13/SC/0544) was granted from
South Central (Oxford A) Research Ethics Committee
(NRES) via the Integrated Research Application System
(IRAS). In accordance with the GCP guidelines, written in-
formed consent prior to randomisation will be mandatory.
Discussion
With this study we aim to clarify whether a diet rich in
Vitamin D and marine omega-3 FAs significantly im-
proves embryo development by improving morphoki-
netic markers of embryo quality. Moreover, we will
identify how a change in diet for six weeks alters the nu-
tritional and immune environment of the developing oo-
cyte, sperm and implanting embryo.
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quality as the primary endpoint rather than number of
live births was taken for a number of reasons. Primarily,
clinical pregnancy rate reflects the success of IVF treat-
ment in subfertility and while dietary intervention may
contribute to this, so do a number of other factors includ-
ing the number of oocytes obtained following ovarian
stimulation with exogenous gonadotrophins. Therefore, if
embryo quality is shown to improve with the dietary inter-
vention, it is more applicable to the general population
and is likely to be of benefit to all trying to conceive and
to their offspring. Secondly, the number needed to recruit
in a trial looking at live birth rates would be far greater
and therefore outside the ability of this study.
It is hoped that the short duration and simplicity of
the intervention will improve both willingness to partici-
pate in the study and compliance. To our knowledge,
this will be the first prospective randomised controlled
trial in humans that examine a dietary intervention and
embryo quality. We consider this study to be achievable
within the planned time frame of 3 years.
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